SCHEMBL29650348

SCHEMBL29650348

CCn1ccc(=O)c2ccccc21

nearest known ligand 0.66

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 9/20 0.50
PGR P06401 7/20 0.50
NR3C2 P08235 7/20 0.50
ALDH1A1 P00352 1/20 0.48
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
MAPT P10636 1/20 0.45
NR4A2 P43354 1/20 0.45
CSNK1D P48730 1/20 0.44
POLB P06746 1/20 0.43
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CCNT1 O60563 1/20 0.42
CDK9 P50750 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2851614 1.00 NR3C1 (0.50) NR3C1PGRNR3C2ALDH1A1MEN1
SCHEMBL8653902 0.85 PDE5A (0.47) NR3C1PGRNR3C2ALDH1A1POLB
SCHEMBL19585644 0.81 NR3C1 (0.44) NR3C1PGRNR3C2ALDH1A1MAPK1
SCHEMBL18926938 0.80 SMN1; SMN2 (0.47) NR3C1PGRNR3C2ALDH1A1MAPK1
SCHEMBL29696630 0.79 HTR6 (0.55) ALDH1A1MEN1KMT2AMAPTMAPK1
SCHEMBL31174785 0.79 NR3C1 (0.46) NR3C1PGRNR3C2ALDH1A1MAPK1
SCHEMBL17111036 0.79 HTR6 (0.55) ALDH1A1MEN1KMT2AMAPTMAPK1
SCHEMBL4886606 0.78 MEN1 (0.49) NR3C1PGRNR3C2ALDH1A1MEN1
SCHEMBL29035965 0.78 NR3C1 (0.43) NR3C1PGRNR3C2ALDH1A1MEN1
SCHEMBL7207556 0.78 NR3C1 (0.42) NR3C1PGRNR3C2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111699189-B Modulators of beta-3 adrenergic receptors useful for treating or preventing heart failure and disorders associated therewith 艾尼纳制药公司 2025-02-18 CN disclosed
CN-109563103-B Modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2022-05-27 CN disclosed